Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.80 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.77 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.72 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.72 |
| ▸ | MAOA | P21397 | 1/20 | 0.72 |
| ▸ | MAOB | P27338 | 1/20 | 0.72 |
| ▸ | APP | P05067 | 5/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | TYR | P14679 | 1/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.69 |
| ▸ | XDH | P47989 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.65 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.65 |
| ▸ | STAT3 | P40763 | 1/20 | 0.65 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.65 |
| ▸ | RELA | Q04206 | 1/20 | 0.65 |
| ▸ | SNCA | P37840 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5315843 | 1.00 | TTR (0.80) | TTRNFE2L2ABCB1AKR1B1MAOA | |
| SCHEMBL671150 | 0.92 | TTR (0.85) | TTRNFE2L2ABCB1AKR1B1MAOA | |
| SCHEMBL30807100 | 0.92 | TTR (0.85) | TTRNFE2L2ABCB1AKR1B1MAOA | |
| SCHEMBL17732299 | 0.92 | TTR (0.85) | TTRNFE2L2ABCB1AKR1B1MAOA | |
| SCHEMBL671149 | 0.92 | TTR (0.85) | TTRNFE2L2ABCB1AKR1B1MAOA | |
| SCHEMBL14782177 | 0.89 | TTR (1.00) | TTRNFE2L2APPMAPTTYR | |
| SCHEMBL3394333 | 0.89 | TTR (0.93) | TTRNFE2L2ABCB1AKR1B1MAOA | |
| SCHEMBL13004148 | 0.89 | TTR (1.00) | TTRNFE2L2APPMAPTTYR | |
| SCHEMBL2945375 | 0.87 | NFE2L2 (0.75) | TTRNFE2L2APPMAPTTYR | |
| SCHEMBL4938984 | 0.87 | NFE2L2 (0.75) | TTRNFE2L2APPMAPTTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4202125-A | — | — | None | — | — | JP | disclosed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2021-07-29 | — | — | US | disclosed |
| US-10426742-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2019-01-24 | — | — | US | disclosed |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2016-10-13 | — | — | US | disclosed |
| WO-2013008175-A1 | METHOD FOR PRODUCING TRANS-RESVERATROL AND THE ANALOGS THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-01-17 | — | — | WO | disclosed |
| JP-H04202125-A | MEDICINE FOR TREATING HEPATOPATHY | TERUMO CORP | 1992-07-22 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | TTR 2988/4885NFE2L2 1303/4885ABCB1 2452/4885 |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | ATG7, SQSTM1, ATF4 | TTR 2045/4885NFE2L2 1941/4885ABCB1 1776/4885 |
| US-10426742-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | TTR 2797/4885NFE2L2 1434/4885ABCB1 2309/4885 |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | TTR 2797/4885NFE2L2 1434/4885ABCB1 2309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.